Evidence map›Paper›PMID 33536255›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guérin Vaccination.

Erik D Layton, Soumik Barman, Damien B Wilburn, Krystle K Q Yu, Malisa T Smith, John D Altman, Thomas J Scriba, Nabil Tahiri, Adriaan J Minnaard, Mario Roederer and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. SpecificFrontiers in immunology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Erik D LaytonDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98109.ORCID 0000-0001-6409-290X
Soumik BarmanDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98109.
Damien B WilburnDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195.ORCID 0000-0002-1255-9982
Krystle K Q YuDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98109.ORCID 0000-0001-8738-1579
Malisa T SmithDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98109.
John D AltmanNational Institutes of Health Tetramer Core Facility, Emory University, Atlanta, GA 30329.ORCID 0000-0001-9733-2359
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 9747, South Africa.ORCID 0000-0002-0641-1359
Nabil TahiriStratingh Institute for Chemistry, University of Groningen 7925, Groningen, the Netherlands.
Adriaan J MinnaardStratingh Institute for Chemistry, University of Groningen 7925, Groningen, the Netherlands.ORCID 0000-0002-5966-1300
Mario RoedererVaccine Research Center, National Institutes of Health, Bethesda, MD 20892; and.
Robert A SederVaccine Research Center, National Institutes of Health, Bethesda, MD 20892; and.
Patricia A DarrahVaccine Research Center, National Institutes of Health, Bethesda, MD 20892; and.ORCID 0000-0002-0035-2802
Chetan SeshadriDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98109; seshadri@u.washington.edu.ORCID 0000-0003-2783-7540
University of Washington · USNational Institutes of Health · USUniversity of Groningen · NLUniversity of Cape Town · ZA

Funding

The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosisR01AI146072 · NIAID · UNIVERSITY OF WASHINGTON · PI CHETAN SESHADRI · 2020 to 2026
$6.0M
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid AntigensR01AI125189 · NIAID · UNIVERSITY OF WASHINGTON · PI SESHADRI, CHETAN · 2016 to 2020
$3.1M
NIAID NIH HHS R01 AI125189NIAID NIH HHS R01 AI146072
6 · The paper itself

Abstract

Intradermal vaccination with

Indexed as

AdolescentAnimalsAntigens, BacterialAntigens, CD1BCG VaccineCell LineChildCohort StudiesDisease Models, AnimalFemaleGlycolipidsGlycoproteinsHealthy VolunteersHumansInjections, IntravenousLungAntigens, BacterialAntigens, CD1BCG VaccineCD1b antigenCD1C protein, humanGlycolipidsGlycoproteins

Identifiers

PMID33536255
PMCPMC7939042
OpenAlexW3127109301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.